Today: 21 May 2026
China pauses Nvidia H200 AI chip orders as CES 2026 fuels data-center rush

China pauses Nvidia H200 AI chip orders as CES 2026 fuels data-center rush

BEIJING, January 8, 2026, 01:39 (GMT+8)

Beijing has asked some Chinese tech companies to halt orders for Nvidia’s H200, a high-end graphics processing unit used to train and run AI models, the Information reported, citing people familiar with the matter. The move came as China weighs whether — and on what terms — it will allow access to the chips, the report said. “China is committed to basing its national development on its own strengths,” said Liu Pengyu, a spokesperson for the Chinese Embassy in the United States. Reuters

The pause underlines how quickly AI hardware has become a bargaining chip in the wider U.S.-China tech fight, with export licences and domestic industrial policy now shaping who gets computing power and when. Nvidia CEO Jensen Huang told reporters this week he was not expecting a formal sign-off from Beijing: “It’s just going to be purchase orders.” Nvidia has said it is seeking U.S. export approvals, and has called for $500 billion in sales from its current Blackwell chips and the next-generation Vera Rubin line by the end of the year. Reuters

At CES in Las Vegas, Lenovo signalled how much urgency sits behind those chips, pitching a data-centre package with Nvidia that it said could cut AI deployments to “weeks.” Lenovo CEO Yang Yuanqing said the tie-up “sets a new benchmark for scalable AI factory design,” as the PC maker pushed an AI platform, new device concepts and a cross-device “Qira” system that can run across Lenovo and Motorola hardware. Reuters

Money is still chasing the buildout. Elon Musk’s xAI said it raised $20 billion in an upsized Series E round, topping its $15 billion target, with investors including Valor Equity Partners, StepStone Group, Fidelity Management & Research Company and the Qatar Investment Authority. Asked for comment, xAI replied: “Legacy Media Lies.” Reuters

Another bet landed on measurement rather than models. LMArena, the startup behind the “Chatbot Arena” style head-to-head tests of large language models — AI systems that generate text — said it raised $150 million at a $1.7 billion valuation, with Felicis and UC Investments co-leading. “To measure the real utility of AI, we need to put it in the hands of real users,” said co-founder and CEO Anastasios Angelopoulos. Reuters

Robots are pulling in deal money too. Mobileye said it would buy humanoid robotics startup Mentee Robotics for about $900 million, extending its self-driving technology into what it calls “embodied AI” — software that senses and acts through a physical machine. Tesla, Figure AI and Agility Robotics are among groups chasing two-legged robots for warehouses and factories, with Mobileye saying first proof-of-concept deployments are expected in 2026. Reuters

But the near-term risk is that policy moves outrun engineering plans. If Beijing hardens its stance on foreign chips — or if U.S. export approvals tighten again — cloud providers and AI labs could face gaps in supply, higher costs and delayed rollouts just as they lock in spending.

For now, markets will watch for any shift in Chinese guidance on H200 orders and for clearer timing on U.S. export licences. The next signal may be mundane: a purchase order that appears — or doesn’t.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
Previous Story

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

Microchip stock slides after surprise sales forecast — traders look to Feb. 5 for proof
Next Story

Microchip stock slides after surprise sales forecast — traders look to Feb. 5 for proof

Go toTop